Digestive Disease Week 2013

Digestive Disease Week 2013 | DDW 2013

Recognized as one of the top 50 medical meetings by the Healthcare Convention & Exhibitors Association, Digestive Disease Week® (DDW) is the world's leading educational forum for academicians, clinicians, researchers, students and trainees working in gastroenterology, hepatology, GI endoscopy, gastrointestinal surgery and related fields.

Conference Coverages

TEMPO Trial Finds Transoral Incisionless Fundoplication Superior to Proton Pump Inhibitors in Some GERD Patients
TEMPO Trial Finds Transoral Incisionless Fundoplication Superior to Proton Pump Inhibitors in Some GERD Patients
Transoral incisionless fundoplication (TIF) was shown to be more effective than taking the maximal proton pump inhibitor (PPI) dose in relieving heartburn, regurgitation, and other troublesome symptoms in patients with refractory gastroesophageal reflux disease (GERD).
Researcher Sorts Through Sea of IBS Remedies
As irritable bowel syndrome (IBS) remains a complicated condition to treat with an etiology that's still unknown, it's difficult for physicians to find the best proven therapies among new remedies and the variety of pharmacological and nondrug options they have been trying for years.
Colonoscopy Prevents Crohn's Disease Post-Operative Endoscopic Recurrence
While it's already clinically understood that most patients with Crohn's disease suffer a recurrence following an intestinal resection, researchers have not evaluated the best strategy to prevent the disease from recurring.
Abdominal, Bowel Symptom Improvement From Linaclotide Meets FDA Standards for IBS-C
Patients taking linaclotide experience clinically meaningful improvement in abdominal and bowel symptoms, which closely correlate with the US Food and Drug Administration's new criteria for irritable bowel syndrome with constipation (IBS-C).
Nonalcoholic Fatty Liver Disease Boosts Cardiovascular Risk, But Lacks Management Plan
Growing evidence suggests increased cardiovascular risk in patients with nonalcoholic fatty liver disease (NAFLD) - in particular nonalcoholic steatohepatitis (NASN) - but no data exists to support a specific management approach.
Cost-Effective pH Testing Can Rule Out GERD
Esophageal pH monitoring is more cost effective than the long-term use of proton-pump inhibitors (PPIs), since it can help rule out gastroesophageal reflux diseases (GERD) and avoid the unneeded costs associated with prolonged medication therapy.
Food Sensitivities Linked to Gut Bacteria in Irritable Bowel Syndrome
While it's important for nutrition and an integral part of patients' lives, food also plays a role in functional gastrointestinal disorders such as irritable bowel syndrome (IBS).
New Direct-Acting Antivirals Promising for Hepatitis C Treatment
Andrew J. Muir, MD, MHS, said having more antiviral hepatitis C drugs in the pipeline could spur more people to accept treatment and improve patient outcomes.
Practitioners Debate Risk of Post-Operative Complications in IBD From Medical Treatment
Presenters at Digestive Disease Week 2013, held May 18-21, 2013, in Orlando, Fla., differed on the risks of surgical complications from the use of biologic agents.

Most Popular


$vacMongoViewPlus$ $vAR$